Native Valve Regurgitation in Pregnancy: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) |
Dima Nimri (talk | contribs) |
||
| Line 29: | Line 29: | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
{|class="wikitable" style="width:80%" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm) | |||
|- | |||
| bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' ACE inhibitors and ARBs should not be given to pregnant patients with valve regurgitation ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|- | |||
|} | |||
===Intervention=== | ===Intervention=== | ||
Revision as of 22:02, 27 October 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Native Valve Regurgitation in Pregnancy[1]
Diagnosis and Follow-up
| Class I |
| "1. All patients with suspected valve regurgitation should undergo a clinical evaluation and TTE before pregnancy.(Level of Evidence: C)" |
| "2. All patients with severe valve regurgitation (stages C and D) should undergo prepregnancy counseling by a cardiologist with expertise in managing patients with VHD during pregnancy.(Level of Evidence: C)" |
| "3. All patients referred for a valve operation before pregnancy should receive prepregnancy counseling by a cardiologist with expertise in managing patients with VHD during pregnancy regarding the risks and benefits of all options for operative interventions, including mechanical prosthesis, bioprosthesis, and valve repair.(Level of Evidence: C)" |
| "4. Pregnant patients with severe regurgitation (stages C and D) should be monitored in a tertiary care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and obstetricians with expertise in managing high-risk cardiac patients.(Level of Evidence: C)" |
| Class IIa |
| "1. Exercise testing is reasonable in asymptomatic patients with severe valve regurgitation (stage C) before pregnancy.(Level of Evidence: C)" |
Medical Therapy
| Class III (Harm) |
| "1. ACE inhibitors and ARBs should not be given to pregnant patients with valve regurgitation (Level of Evidence: B)" |
Intervention
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD (2014). "2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J. Am. Coll. Cardiol. 63 (22): 2438–88. doi:10.1016/j.jacc.2014.02.537. PMID 24603192.